332 related articles for article (PubMed ID: 18588281)
1. Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives.
Cappellacci L; Franchetti P; Vita P; Petrelli R; Lavecchia A; Jayaram HN; Saiko P; Graser G; Szekeres T; Grifantini M
J Med Chem; 2008 Jul; 51(14):4260-9. PubMed ID: 18588281
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of C-methyl-beta-D-ribofuranosyladenine nucleoside ribonucleotide reductase inhibitors.
Franchetti P; Cappellacci L; Pasqualini M; Petrelli R; Vita P; Jayaram HN; Horvath Z; Szekeres T; Grifantini M
J Med Chem; 2005 Jul; 48(15):4983-9. PubMed ID: 16033277
[TBL] [Abstract][Full Text] [Related]
3. From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine.
Petrelli R; Meli M; Vita P; Torquati I; Ferro A; Vodnala M; D'Alessandro N; Tolomeo M; Del Bello F; Kusumanchi P; Franchetti P; Grifantini M; Jayaram HN; Hofer A; Cappellacci L
Bioorg Med Chem Lett; 2014 Nov; 24(22):5304-9. PubMed ID: 25304896
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of novel N6-substituted and 2,N6-disubstituted adenine ribo- and 3'-C-methyl-ribonucleosides as antitumor agents.
Cappellacci L; Petrelli R; Franchetti P; Vita P; Kusumanchi P; Kumar M; Jayaram HN; Zhou B; Yen Y; Grifantini M
Eur J Med Chem; 2011 May; 46(5):1499-504. PubMed ID: 21349610
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3'-C-methyladenosine in leukaemia cells.
Meli M; Tolomeo M; Grifantini M; Mai A; Cappellacci L; Petrelli R; Rotili D; Ferro A; Saiko P; Szekeres T; Dusonchet L
Int J Oncol; 2011 May; 38(5):1427-36. PubMed ID: 21318222
[TBL] [Abstract][Full Text] [Related]
6. Azinyl and diazinyl hydrazones derived from aryl N-heteroaryl ketones: synthesis and antiproliferative activity.
Easmon J; Heinisch G; Pürstinger G; Langer T; Osterreicher JK; Grunicke HH; Hofmann J
J Med Chem; 1997 Dec; 40(26):4420-5. PubMed ID: 9435912
[TBL] [Abstract][Full Text] [Related]
7. Understanding the antitumor activity of novel hydroxysemicarbazide derivatives as ribonucleotide reductase inhibitors using CoMFA and CoMSIA.
Raichurkar AV; Kulkarni VM
J Med Chem; 2003 Oct; 46(21):4419-27. PubMed ID: 14521406
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activity of 5'-deoxy-4'-thio-L-nucleosides.
Cong L; Zhou W; Jin D; Wang J; Chen X
Chem Biol Drug Des; 2010 Jun; 75(6):619-27. PubMed ID: 20337785
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation, and molecular modeling of ribose-modified adenosine analogues as adenosine receptor agonists.
Cappellacci L; Franchetti P; Pasqualini M; Petrelli R; Vita P; Lavecchia A; Novellino E; Costa B; Martini C; Klotz KN; Grifantini M
J Med Chem; 2005 Mar; 48(5):1550-62. PubMed ID: 15743197
[TBL] [Abstract][Full Text] [Related]
10. Preliminary SAR analysis of novel antiproliferative N(6),5'-bis-ureidoadenosine derivatives.
Peterson MA; Oliveira M; Christiansen MA; Cutler CE
Bioorg Med Chem Lett; 2009 Dec; 19(23):6775-9. PubMed ID: 19850476
[TBL] [Abstract][Full Text] [Related]
11. N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice.
Franchetti P; Cappellacci L; Vita P; Petrelli R; Lavecchia A; Kachler S; Klotz KN; Marabese I; Luongo L; Maione S; Grifantini M
J Med Chem; 2009 Apr; 52(8):2393-406. PubMed ID: 19317449
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities.
Son JK; Zhao LX; Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong TC; Jeong BS; Lee CS; Lee ES
Eur J Med Chem; 2008 Apr; 43(4):675-82. PubMed ID: 17673337
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel 6-(4-substituted piperazine-1-yl)-9-(β-D-ribofuranosyl)purine derivatives, which lead to senescence-induced cell death in liver cancer cells.
Tuncbilek M; Guven EB; Onder T; Cetin Atalay R
J Med Chem; 2012 Apr; 55(7):3058-65. PubMed ID: 22409771
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of 3- and 5-amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
Liu MC; Lin TS; Cory JG; Cory AH; Sartorelli AC
J Med Chem; 1996 Jun; 39(13):2586-93. PubMed ID: 8691457
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxic evaluation of substituted urea derivatives as inhibitors of human-leukemia K562 cells.
Cao P; Huang XF; Ding H; Ge HM; Li HQ; Ruan BF; Zhu HL
Chem Biodivers; 2007 May; 4(5):881-6. PubMed ID: 17511003
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structure and hypoxic cytotoxicity of 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
Jiang F; Weng Q; Sheng R; Xia Q; He Q; Yang B; Hu Y
Arch Pharm (Weinheim); 2007 May; 340(5):258-63. PubMed ID: 17464965
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of novel acyclic versions of Neplanocin A.
Wu Y; Hong JH
Arch Pharm (Weinheim); 2005 Nov; 338(11):517-21. PubMed ID: 16281309
[TBL] [Abstract][Full Text] [Related]
18. [Design and synthesis of 3'-methyl-furanonucleosides and their anti-tumor activities].
Shi LH; Jin DZ; Zhou WC; Wang J; Chen XH
Yao Xue Xue Bao; 2009 Jul; 44(7):747-53. PubMed ID: 19806914
[TBL] [Abstract][Full Text] [Related]
19. Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
Cory AH; Sato A; Thompson DP; Cory JG
Oncol Res; 1996; 8(10-11):449-56. PubMed ID: 9114437
[TBL] [Abstract][Full Text] [Related]
20. More potent linear peptide inhibitors of mammalian ribonucleotide reductase.
Tan C; Gao Y; Kaur J; Cooperman BS
Bioorg Med Chem Lett; 2004 Nov; 14(21):5301-4. PubMed ID: 15454215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
